GGrantIndex
← Leaderboards

Lynda Chin

Dana-Farber Cancer Institute

$27,359,435
Attributed
$40,761,775
Total exposure
17
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.9M · FY200517
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$43,518,787 · 18

By mechanism

U24$15,987,999 · 1
U01$6,765,032 · 2
RC2$6,635,349 · 1
R01$5,086,272 · 2
U54$4,496,644 · 6
P01$3,055,767 · 2

Top collaborators

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Genomics

Research focus

GenomicsGeneticMalignant NeoplasmsTumorMelanomaBaseSamplingBiologicalOncogenesProgramsMutationGenetically Engineered MouseValidationClinical TrialsGenesMouse ModelIn VivoEngineeringIn VitroCancer GenomicsResponseResourcesCellsGenome

Grant awards (70)

Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models$341,806
P01 · FY2017 · CA · contact PI
The Cancer Genome Atlas Data Analysis Center$750,000
U24 · FY2016 · CA
Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models$293,957
P01 · FY2016 · CA · contact PI
Cutaneous Oncology and Melanoma$85,327
P30 · FY2016 · CA · contact PI
Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models$293,957
P01 · FY2015 · CA · contact PI
Role of Tumor in Therapeutic Response and Resistance$261,117
U54 · FY2015 · CA · contact PI
Genetically Engineered Mouse Models for TMEN Research$93,838
U54 · FY2015 · CA · contact PI
Cutaneous Oncology and Melanoma$85,348
P30 · FY2015 · CA · contact PI
The Cancer Genome Atlas Data Analysis Center$1,100,000
U24 · FY2014 · CA
Biological annotation of TCGA data$1,097,803
U01 · FY2014 · CA
Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models$285,140
P01 · FY2014 · CA · contact PI
Role of Tumor in Therapeutic Response and Resistance$254,210
U54 · FY2014 · CA · contact PI
Genetically Engineered Mouse Models for TMEN Research$91,116
U54 · FY2014 · CA · contact PI
Cutaneous Oncology and Melanoma$80,794
P30 · FY2014 · CA · contact PI
The Cancer Genome Atlas Data Analysis Center$3,167,900
U24 · FY2013 · CA
Role of Tumor Stroma in Therapeutic Response and Resistance$954,554
U54 · FY2013 · CA · contact PI
Biological annotation of TCGA data$853,708
U01 · FY2013 · CA
Uses of GEM models for Translational Cancer Research$711,971
U01 · FY2013 · CA · contact PI
Role of Tumor in Therapeutic Response and Resistance$451,222
U54 · FY2013 · CA · contact PI
Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models$293,957
P01 · FY2013 · CA · contact PI
Human Specimens$129,794
U54 · FY2013 · CA · contact PI
Cutaneous Oncology and Melanoma$78,203
P30 · FY2013 · CA · contact PI
The Cancer Genome Atlas Data Analysis Center$2,493,796
U24 · FY2012 · CA · contact PI
Biological annotation of TCGA data$948,524
U01 · FY2012 · CA
Role of Tumor Stroma in Therapeutic Response and Resistance$872,340
U54 · FY2012 · CA · contact PI
Uses of GEM models for Translational Cancer Research$760,324
U01 · FY2012 · CA · contact PI
Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer$639,047
RC2 · FY2012 · CA
Identification and Characterization of Kinase Oncogenes in Glioblastoma$363,477
P01 · FY2012 · CA · contact PI
Identification of Resistance-Conferring Stromal Alterations in BRAF Mutant Melano$212,693
U54 · FY2012 · CA · contact PI
ADMINISTRATIVE CORE$169,812
U54 · FY2012 · CA · contact PI
Cutaneous Oncology and Melanoma$85,332
P30 · FY2012 · CA · contact PI
Genetically Engineered Mouse Models for TMEN Research$75,830
U54 · FY2012 · CA · contact PI
The Cancer Genome Atlas Data Analysis Center$2,535,444
U24 · FY2011 · CA · contact PI
Role of Tumor Stroma in Therapeutic Response and Resistance$930,118
U54 · FY2011 · CA · contact PI
Uses of GEM models for Translational Cancer Research$817,169
U01 · FY2011 · CA · contact PI
The genetic Basis of Melanoma Metastasis$358,437
R01 · FY2011 · CA · contact PI
Identification and Characterization of Kinase Oncogenes in Glioblastoma$328,583
P01 · FY2011 · CA · contact PI
Genomics and Bioinformatics$135,097
P50 · FY2011 · CA · contact PI
Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer$2,998,170
RC2 · FY2010 · CA
The Cancer Genome Atlas Data Analysis Center$2,582,202
U24 · FY2010 · CA · contact PI
Uses of GEM models for Translational Cancer Research$800,533
U01 · FY2010 · CA · contact PI
The Cancer Genome Atlas Data Analysis Center$693,768
U24 · FY2010 · CA · contact PI
The genetic Basis of Melanoma Metastasis$369,522
R01 · FY2010 · CA · contact PI
Identification and Characterization of Kinase Oncogenes in Glioblastoma$329,212
P01 · FY2010 · CA · contact PI
Genomics and Bioinformatics$148,969
P50 · FY2010 · CA · contact PI
Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer$2,998,132
RC2 · FY2009 · CA
The Cancer Genome Atlas Data Analysis Center$2,664,889
U24 · FY2009 · CA · contact PI
Uses of GEM models for Translational Cancer Research$775,000
U01 · FY2009 · CA · contact PI
The genetic Basis of Melanoma Metastasis$369,522
R01 · FY2009 · CA · contact PI
Identification and Characterization of Kinase Oncogenes in Glioblastoma$307,800
P01 · FY2009 · CA · contact PI
Genomics and Bioinformatics$147,615
P50 · FY2009 · CA · contact PI
The genetic Basis of Melanoma Metastasis$369,522
R01 · FY2008 · CA · contact PI
Identification and Characterization of Kinase Oncogenes in Glioblastoma$217,878
P01 · FY2008 · CA · contact PI
Genomics and Bioinformatics$142,196
P50 · FY2008 · CA · contact PI
The genetic Basis of Melanoma Metastasis$369,522
R01 · FY2007 · CA · contact PI
Genomic & Genetic Characterization of Amplicons in GBMs$288,607
R01 · FY2007 · CA · contact PI
Genomics and Bioinformatics$129,046
P50 · FY2007 · CA · contact PI
MET Activation in Melanoma Genesis and Progression$348,250
R01 · FY2006 · CA · contact PI
Genomic & Genetic Characterization of Amplicons in GBMs$297,227
R01 · FY2006 · CA · contact PI
MET Activation in Melanoma Genesis and Progression$356,631
R01 · FY2005 · CA
Genomic &Genetic Characterization of Amplicons in GBMs$304,380
R01 · FY2005 · CA
MET Activation in Melanoma Genesis and Progression$356,631
R01 · FY2004 · CA
Genomic &Genetic Characterization of Amplicons in GBMs$304,380
R01 · FY2004 · CA
MET Activation in Melanoma Genesis and Progression$356,631
R01 · FY2003 · CA
Genomic &Genetic Characterization of Amplicons in GBMs$304,380
R01 · FY2003 · CA
MET Activation in Melanoma Genesis and Progression$332,630
R01 · FY2002 · CA
MOLECULAR PATHOGENESIS OF MALIGNANT MELANOMA$124,599
K08 · FY2002 · AR
MOLECULAR PATHOGENESIS OF MALIGNANT MELANOMA$124,599
K08 · FY2001 · AR
Identification of melanoma metastasis loci by array CGH$0
P30 · FY2001 · AR
MOLECULAR PATHOGENESIS OF MALIGNANT MELANOMA$124,599
K08 · FY2000 · AR